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Brugada Syndrome
Local Depolarization Abnormalities
Are the Dominant Pathophysiologic Mechanism
for Type 1 Electrocardiogram in Brugada Syndrome
A Study of Electrocardiograms, Vectorcardiograms, and
Body Surface Potential Maps During Ajmaline Provocation
Pieter G. Postema, MD,* Pascal F. H. M. van Dessel, MD, PHD,*
Jan A. Kors, PHD,§ Andre C. Linnenbank, PHD,‡ Gerard van Herpen, MD, PHD,§
Henk J. Ritsema van Eck, MD, PHD,§ Nan van Geloven, MSC,*† Jacques M. T. de Bakker, PHD,‡
Arthur A. M. Wilde, MD, PHD,*‡ Hanno L. Tan, MD, PHD*‡
Amsterdam and Rotterdam, the Netherlands
Objectives We sought to obtain new insights into the pathophysiologic basis of Brugada syndrome (BrS) by studying
changes in various electrocardiographic depolarization and/or repolarization variables that occurred with the
development of the signature type 1 BrS electrocardiogram (ECG) during ajmaline provocation testing.
Background BrS is associated with sudden cardiac death. Its pathophysiologic basis, although unresolved, is believed to re-
side in abnormal cardiac depolarization or abnormal repolarization.
Methods Ajmaline provocation was performed in 269 patients suspected of having BrS with simultaneous recording of
ECGs, vectorcardiograms, and 62-lead body surface potential maps.
Results A type 1 ECG was elicited in 91 patients (BrS patients), 162 patients had a negative test result (controls), and
16 patients had an abnormal test result. Depolarization abnormalities were more prominent in BrS patients and
were mapped to the right ventricle (RV) by longer right precordial filtered QRS complex durations (142  23 ms
vs. 125  14 ms, p  0.01) and right terminal conduction delay (60  11 ms vs. 53  9 ms, p  0.01). Repo-
larization abnormalities remained concordant with depolarization abnormalities as indicated by steady low non-
dipolar content (12  8% vs. 8  4%, p  NS), lower spatial QRS-T integrals (33  12 mV·ms vs. 40  16
mV·ms, p  0.05), similar spatial QRS-T angles (92  39° vs. 87  31°, p  NS), similar Tpeak-Tend interval
(143  36 ms vs. 138  25 ms, p  NS), and similar Tpeak-Tend dispersion (47  37 ms vs. 45  27 ms, p  NS).
Conclusions The type 1 BrS ECG is characterized predominantly by localized depolarization abnormalities, notably (terminal)
conduction delay in the RV, as assessed with complementary noninvasive electrocardiographic techniques. We
could not define a separate role for repolarization abnormalities but suggest that the typical signs of repolariza-
tion derangements seen on the ECG are secondary to these depolarization abnormalities. (J Am Coll Cardiol
2010;55:789–97) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.11.033p
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Orugada syndrome (BrS) is associated with sudden cardiac
eath by ventricular tachycardia and/or fibrillation (VT/VF)
1). The ongoing controversy about the best treatment (2)
equires better understanding of its pathophysiology. The
ignature type 1 electrocardiogram (ECG), mandatory for
he BrS diagnosis and linked to VT/VF, consists of right
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Depolarization Changes Dominate Brugada Syndrome February 23, 2010:789–97(e.g., ajmaline) is used to evoke a
type 1 ECG (1). Because electro-
cardiographic abnormalities are
found in right precordial leads
and VT/VF mostly originates
from the right ventricle (RV), BrS
is regarded an RV disorder (1).
There are 2 principal hypotheses
on its pathophysiologic basis (re-
viewed in Meregalli et al. [3]): the
“depolarization disorder hypothe-
sis,” that is, RV conduction delay
combined with mild structural RV
derangements (4 – 6), and the
“repolarization disorder hypoth-
esis,” that is, transmural disper-
sion of RV action potential mor-
phology (7). We aimed to gain
more pathophysiologic insight by
using 3 noninvasive electrocar-
diographic assays (ECG, vector-
cardiogram [VCG], and body
surface potential map [BSPM])
in parallel in patients who under-
went ajmaline testing. This al-
lowed us to analyze which changes
occurred when a type 1 ECG
merged. Using the synergy of the different sets of information
n global and local depolarization and repolarization events
rom these different assays, we found that local depolarization
bnormalities are the dominant pathophysiologic mechanism
f BrS.
ethods
atients and the ajmaline protocol. In this study, 269
onsecutive subjects who underwent ajmaline testing were
ncluded. These subjects had not previously exhibited a type
ECG and underwent testing because of symptoms, a
uspicious ECG, or family screening. The type 1 BrS ECG
as defined as 0.2 mV J amplitude with coved ST-T
egments gradually descending into a negative T-wave in
2 right precordial leads (1). Studies, performed after
ritten informed consent, were approved by the institu-
ional ethics committee.
Ajmaline was infused in repeated boluses of 10 mg/min
ntil the target dose (1 mg/kg) was reached, and a type 1
CG or arrhythmias occurred. Test results were defined as
ositive if ajmaline infusion evoked a type 1 ECG (and
ubjects as BrS patients when the other diagnostic criteria
ere also met [1]). Tests in which excessive QRS widening
40% of baseline values) or arrhythmias occurred, but no
ype 1 ECG, were defined as abnormal and were excluded
rom further analysis. All other tests were defined as
egative (and subjects as controls). In BrS patients or those
Abbreviations
and Acronyms
BrS  Brugada syndrome
BSPM  body surface
potential map
ECG  electrocardiogram
fQRSD  filtered QRS
complex duration
LAS40  duration of low-
amplitude signal (<40 V)
in the terminal part of the
filtered QRS complex
LP  late potential
RMS40  root mean
square value of voltage in
the terminal 40 ms of the
filtered QRS complex
RV  right ventricle/
ventricular
SCN5a  gene that
encodes the -subunit of
the cardiac sodium channel
VCG  vectorcardiogram
VT/VF  ventricular
tachycardia/ventricular
fibrillationith an abnormal test result, DNA analysis for SCN5a (theene that encodes the -subunit of the cardiac sodium
hannel) mutations was performed. Because SCN5a muta-
ions and sex may modify disease expressivity (1), secondary
nalyses on these modifiers were performed.
ecordings. In all 269 subjects, ECGs were recorded as
escribed previously (8). From modified 12-lead ECGs
conventional V3 and V5 positioned in the third intercostal
pace cranially to V1 and V2 [V1ic3 and V2ic3, respec-
ively]) (Fig. 1), 10-s recordings were saved at baseline, at 1
inute after each ajmaline bolus, and during wash out.
CGs were recorded simultaneously with ECGs in all
ubjects and additional Frank XYZ leads (E/I/M/H; C 
4, A  V6, F  left leg) (Fig. 1). Additional continuous
SPM recordings before, during, and after ajmaline prov-
cation were made in the first 95 subjects with a customized
ecording system using a grid of 62 unipolar leads on 14
exible straps (Fig. 1), as described previously (9–11).
CG and VCG analyses. All digital electrocardiographic
nd vectorcardiographic recordings were first automatically
nalyzed with the modular ECG analysis system MEANS
12) and manually verified. To aid differentiation between
epolarization and repolarization abnormalities at baseline
nd at peak ajmaline effect, we studied simultaneous record-
ngs at these time points.
From the ECG, we analyzed conventional depolarization
arameters (P, PQ, QRS [all in milliseconds] and the QRS
xis [in degrees]) and repolarization parameters (JT, QT,
Tc [all in milliseconds] and the T axis [in degrees]).
-wave end was defined with a tangent, and QT was
V I
LR
DRL F
Additional Frank leads
Body surface map leads
Leads selected for right and left precordial set
I E M
H
Figure 1 ECG, VCG, and BSPM Lead Placement
Electrode positions for the modified electrocardiogram (ECG) (black circles),
vectorcardiogram (VCG) leads (blue circles) and body surface potential map
(BSPM) leads (red circles) used during the ajmaline provocation tests, BSPM
leads selected as right and left precordial (squares). DRL  driven right leg
electrode; F  left leg electrode; H  Frank lead; I  Frank lead; L  left arm
electrode; M  Frank lead; R  right arm electrode.
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February 23, 2010:789–97 Depolarization Changes Dominate Brugada Syndromeorrected for heart rate (QTc) using Bazett’s formula (13).
he tallest right precordial J amplitude (V) among V1, V2,
1ic3, and V2ic3 was determined (Fig. 2). As a measure of
ispersion of repolarization (regarded as transmural or
lobal dispersion of repolarization [14–16]), we studied
aximal Tpeak-Tend interval and Tpeak-Tend dispersion
maximal-minimal value) over the precordial leads. From
his analysis, we excluded biphasic T waves and T waves
ith amplitudes 100 V.
VCGs may reveal abnormalities in depolarization and/or
epolarization sequence not available on a 12-lead ECG
Fig. 2) (17,18). To assess depolarization, we divided the
patial QRS loop into 4 parts of equal length. For each part,
e measured the duration (in milliseconds) and axis (in
egrees) in the transverse plane. To study interaction
etween repolarization and depolarization, we measured the
patial QRS T angle (in degrees) and the vector magnitude
mV·ms) of the spatial QRS T integral (19,20). Studying
he transverse plane of the VCG allows assessment of RV
erminal conduction slowing (17,18). Abnormally increased
< <
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Right-
 precordial
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precordial
Right-
 precordial
LAS40 = 35 m
RMS40 = 38
fQRSD = 14
fQRSD = 12
fQRSD = 12
fQRSD = 9
fQRSD = 9
V1
V2ic3
II
V2
< << << <
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J amplitude
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II
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ECG Late potentials
A B
Figure 2 ECG, VCG, and BSPM Parameters
Simultaneously recorded electrocardiogram (ECG), vectorcardiogram (VCG), and bo
patient with Brugada syndrome with SCN5a mutation. (A) ECG: Note the type 1 EC
root mean square filtered signal from reconstructed Frank, left and right precordia
larly at peak ajmaline effect. Shown are: onset/offset fQRSD (vertical lines), dura
of signal in terminal 40 ms (RMS40). (C) VCG: QRS T loop in frontal, sagittal, and
(transverse plane), particularly at peak ajmaline effect, along with rightward axis d
QRS loop direction. Nondipolar content: body surface (D) QRS T integral maps. No
positions of the sternum and vertebral column at the top of the map, positions ofpatial QRS T angles implicate discordant repolarization
nd predict cardiovascular mortality (19). The vector mag-
itude of the spatial QRS T integral, or ventricular gradient,
s a 3-dimensional measure of heterogeneity of action
otential duration (20). It was postulated that increased
ransmural dispersion of RV action potential morphology in
rS (7) should result in an increased ventricular gradient (20).
SPM analyses. A BSPM is better suited than a 12-lead
CG to uncover local abnormal electrophysiologic phe-
omena (9,11). BSPMs were processed using customized
oftware (21). One-minute intervals were selected at base-
ine and peak ajmaline effect (similar to ECGs/VCGs). In
his way, electrocardiograms could be averaged to exclude
rtifacts and reduce noise while preserving short-term ef-
ects during ajmaline infusion (ajmaline has a half-life of
inutes). On average, per map 1.2 0.3 leads were rejected
ecause of unacceptable quality. Depolarization was as-
essed by late potential (LP) analysis and repolarization by
ondipolar content. LPs indicate abnormal ventricular con-
uction and are related to re-entrant tachyarrhythmias (22).
Non-dipolar content
Non-dipolar content = 8%
Non-dipolar content = 10%
VCG
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C D
face potential map (BSPM) parameters at baseline and peak ajmaline effect in a
eak ajmaline effect. Vertical lines indicate time intervals. (B) Late potentials:
. Note the prolongation of right precordial filtered QRS duration (fQRSD), particu-
terminal low-amplitude signal 40 V (LAS40), and root mean square voltage
verse planes. Note the terminal conduction slowing in the spatial QRS loop
n (double arrowhead). Dashes: 2-ms intervals; black arrows (single arrowhead):
modest QRS T integral change from baseline to peak ajmaline effect. Shown are
S T integral extremes ( and ), and corresponding nondipolar content values.s
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Depolarization Changes Dominate Brugada Syndrome February 23, 2010:789–97ondipolar content permits evaluation of local ventricular
epolarization abnormalities independent of ventricular ac-
ivation sequence (23). High nondipolar content indicates
ocal disparity of repolarization duration and has been used
o assess vulnerability to ventricular arrhythmias (9–11,23).
For LPs, we assessed both global and local relevance.
lobal relevance was studied in reconstructed Frank leads
nd local relevance in sets of right and left precordial BSPM
eads (Fig. 1). The right precordial set was used to evaluate
he contribution of abnormal RV depolarization, and the
eft precordial set to assess this for the left ventricle. After
pplication of a bidirectional Butterworth 25-Hz high-pass
lter, the root mean square filtered signal was computed.
nset and end of the filtered QRS complex were taken at
he time locations where signal amplitude became 3 V
or 5 ms. We applied this conservative and arbitrary fixed
oise cutoff because we dealt with nonstationary signals
etween baseline and peak ajmaline effect. A noise-driven
utoff could be detrimental to between-subjects comparison
22). On average, noise levels were similar between BrS
atients and controls and remained similar on ajmaline
dministration (Frank: 0.95 0.35 V, left precordial: 1.25
.46 V, right precordial: 1.20  0.39 V). After verifying
orrect marker placement, we calculated the following
arameters: the duration of the filtered QRS complex
fQRSD), the duration (in milliseconds) of the terminal
ow-amplitude signal 40 V (LAS40), and the root mean
quare voltage (RMS40) (in microvolts) of signal in the
erminal 40 ms) (Fig. 2).
To obtain nondipolar content, we calculated mean total
RS T integral maps as described previously (9,11). In
hort, the first 12 eigenvectors were derived, and the QRS T
ntegral map was expressed in terms of these eigenvectors.
he first 3 eigenvectors of the eigenvector set reveal (nor-
al) dipolar patterns, whereas eigenvectors 4 through 12
how (increasingly abnormal) nondipolar or multipolar pat-
erns (23). Therefore, the nondipolar content of each map as
measure of abnormal repolarization was defined as the
ontribution of eigenvectors 4 through 12 relative to the
ontribution of eigenvectors 1 through 12 and expressed as
ercentage (Fig. 2) (23).
tatistical analyses. Statistical analyses were performed
sing SPSS version 15.0 (SPSS Inc., Chicago, Illinois).
ontinuous variables are presented as mean  SD and
ategorical variables as the number (percentage) of patients.
atients with an abnormal test result (see the “Patients and
he ajmaline protocol” section) were excluded from compar-
sons. We studied the differences between BrS patients and
ontrols at baseline and at peak ajmaline effect. Secondary
nalyses were performed to assess differences between BrS
atients regarding SCN5a mutations, symptoms, and sex.
or continuous parameters, when histogram analyses con-
rmed normal distribution, an unpaired t test was used to
ompare groups, with equal or unequal variances assumed
ccording to Levene’s test. For skewed distributions, aann-Whitney U test was used. The Fisher exact test was csed to compare categorical variables. Furthermore, based
n LP analysis results, the presence of a correlation between
ight-to-left differences in fQRSD and maximal J amplitude
n right precordial leads was estimated using Spearman’s
orrelation coefficient. A p value 0.05 was accepted as the
evel of statistical significance.
esults
aseline characteristics. Ajmaline test results were posi-
ive in 91 (34%), negative in 162 (60%), and abnormal in 16
6%) subjects (Table 1). In 1 patient, sinus arrest occurred.
ll patients with a positive test result met the BrS consensus
riteria (1). Age and sex distributions were similar, as were
ndications for testing and medical histories (Table 1).
CN5a mutations were found in 20% of BrS patients (11
ales, 7 females) and 44% of patients with an abnormal test
esult (3 males, 4 females).
Because ajmaline infusion was stopped when a type 1
CG occurred, BrS patients received less ajmaline than
ontrols (90  19% vs. 102  4% of the target dose, p 
.01). BrS patients with SCN5a mutations required less
jmaline than BrS patients without SCN5a mutations (81
2% vs. 92  18% of the target dose, p  0.05). Likewise,
ale BrS patients required less ajmaline than female BrS
atients (85  23% vs. 94  14% of the target dose, p 
.05). Symptomatic and asymptomatic BrS patients re-
uired similar amounts of ajmaline.
CG depolarization and repolarization parameters.
CG parameters are summarized in Table 2. At baseline,
rS patients already had depolarization abnormalities with
onger P, PQ, and QRS than controls (118 16 ms vs. 114 13
s, 167 30 ms vs. 156 21 ms, and 108 18 ms vs. 102
1 ms, respectively; all p values 0.05). Ajmaline caused
aster heart rates and atrial, atrioventricular, and ventricular
aseline CharacteristicsTable 1 Baseline Characteristics
BrS
(n  91)
Controls
(n  162)
Abnormal Test
(n  16)
Age (yrs) 43  13 41  15 46  14
Male 42 (46) 99 (61) 8 (50)
History of syncope 12 (13) 33 (20) 2 (13)
History of VT/VF 4 (4) 9 (6) 0 (0)
Family history of VT/VF/SCD 40 (44) 87 (54) 8 (50)
SCN5a mutation 18 (20) N/A 7 (44)
Ajmaline infused (mg) 64  19*† 76  14 79  19
Percentage of maximum
ajmaline target dose
90  19*† 102  4 102  7
Indication for test
Suspicious ECG 16 (18) 26 (15) 4 (25)
Syncope/VT/VF 12 (13) 31 (19) 0 (0)
Family screening 63 (69) 105 (65) 12 (75)
VCG 91 (100) 162 (100) 16 (100)
BSPM 40 (44) 54 (33) 1 (6)
ata are mean  SD or n (%). *p  0.01 for Brugada syndrome (BrS) patients versus controls.
Skewed distribution, Mann-Whitney test.
BSPM body surface potential map; ECG electrocardiogram; N/A not analyzed; SCD sudden
ardiac death; VCG  vectorcardiogram; VF  ventricular fibrillation; VT ventricular tachycardia.
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February 23, 2010:789–97 Depolarization Changes Dominate Brugada Syndromeonduction slowing in both groups. Although BrS patients
eceived less ajmaline, more conduction slowing developed
n them on ajmaline infusion, as evidenced by more widening
f P waves (35 17 ms vs. 30 14 ms net increase, p 0.01)
nd QRS duration (39 20 ms vs. 31 12 ms net increase,
 0.01). Conversely, BrS patients had shorter JT intervals
t baseline and peak ajmaline effect (266  34 ms vs. 277 
8 ms and 254  27 ms vs. 267  27 ms, respectively; all
values 0.01), resulting in similar QT and QTc intervals
n both groups. Maximal Tpeak-Tend intervals and Tpeak-
end dispersion were also similar. BrS patients had more
eftward deviation of the QRS axis and T axis, particularly
t peak ajmaline effect (QRS axis: 13  68° vs. 31  62°,
axis: 31  25° vs. 43  17°, both p values 0.05).
bviously, right precordial J amplitude at peak ajmaline
<
<
<
start
stop
<
<
A B
Figure 3 ECG, Late Potentials, and J-Amplitude
(A) Three-dimensional representation of P-QRS-T complex in lead V1 during ajmalin
P-wave prolongation during ajmaline infusion, J/ST-segment elevation, and rather c
line infusion, and type 1 ECG at peak ajmaline effect. (B) Three-dimensional repre
lead V1 during ajmaline infusion in a BrS patient. Note the development of late po
amplitude (colors), and start/stop moment of ajmaline infusion. (C) Relationship b
ECG ParametersTable 2 ECG Parameters
BrS
(n  9
Heart rate (beats/min) 69
P-wave duration (ms) 118
PQ interval (ms) 167
QRS duration (ms) 108
JT interval (ms) 266
QT interval (ms) 375
QTc interval (ms) 400
Maximum Tpeak-Tend (ms) 119
Tpeak-Tend dispersion (ms) 34
QRS axis (°) 20
T axis (°) 38
Maximum right precordial J amplitude (V) 131
Data are mean  SD. *p  0.05. †p  0.01 for Brugada syndrome (B
ECG  electrocardiogram.ffect was greater in BrS patients (352  161 V vs. 141 
6 V, p  0.01) (Figs. 2 and 3, Table 2).
epolarization abnormalities on BSPM. LP analysis
Fig. 2, Table 3) revealed significant depolarization abnor-
alities in BrS patients on type 1 ECG induction. Global
P analysis, conducted with the use of Frank leads, revealed
hat BrS patients had lower RMS40 and longer LAS40,
oth at baseline and peak ajmaline effect (RMS40 baseline:
4  23 V vs. 62  37 V; RMS40 peak ajmaline effect:
5  7 V vs. 21  15 V; LAS40 baseline: 32  11 ms
s. 28  9 ms; LAS40 peak ajmaline effect: 52  17 ms vs.
3  12 ms; all p values 0.05). Furthermore, we found
isparate results for the left ventricle and RV. In left
recordial leads, LP measures were similar. In contrast, in
ight precordial leads, fQRSD and LAS40 were longer and
60
40
20
0
-20
0 250 500 750
p<0.001
<
<
<
start
stop
C
ocation test in a patient with Brugada syndrome (BrS). Note PR interval and
nt QT interval. Shown are: signal amplitude (colors), start/stop moment of ajma-
ion of the root mean square filtered signal at the end of the QRS complex in
s separating from the QRS complex during ajmaline infusion. Shown are: signal
n maximal J amplitude in right precordial leads and the difference in duration of
seline Peak Ajmaline
Controls
(n  162)
BrS
(n  91)
Controls
(n  162)
68 13 80 12 79 12
114 13 155 22† 144 17
156 21 217 31† 205 25
102 11 147 23† 133 14
277 28 254 27† 267 27
379 26 403 34 400 27
399 28 462 29 455 30
116 21 143 36 138 25
34 20 47 37 45 27
39 39 13 68* 31 62
42 20 31 25† 43 17
96 67 352 161† 141 86
tients versus controls.<
e prov
onsta
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tential
etwee
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Depolarization Changes Dominate Brugada Syndrome February 23, 2010:789–97MS40 was lower at baseline in BrS patients. These
ifferences became even greater at peak ajmaline effect
fQRSD: 142  23 ms vs. 125  14 ms, RMS40: 15  9
V vs. 28  19 V; LAS40: 51  18 ms vs. 36  15 ms;
ll p values 0.01) (Figs. 2 and 3, Table 3).
epolarization abnormalities on VCG. VCG analysis
Table 4) revealed that most conduction delay in the spatial
RS loop resided in its terminal quarter in both patient
roups. This was most apparent in BrS patients as the
ifference between BrS patients and controls increased even
urther at peak ajmaline effect (60  11 ms vs. 53  9 ms,
 0.01) (Fig. 2, Table 4). The rightward deviation of the
xis of this terminal quarter of the QRS loop when a type 1
CG occurred (55  39° vs. 69  25°, p  0.01) (Fig. 2,
able 4) indicated RV terminal conduction slowing (Fig. 2).
epolarization abnormalities on BSPM and VCG. BSPM
nalysis did not reveal local repolarization abnormalities in
rS patients. Nondipolar content remained low and was
imilar to that of controls (baseline: 10  5% vs. 8  4%,
eak ajmaline effect: 12 8% vs. 10 6%; pNS) (Fig. 2,
able 3). Only a few subjects had abnormal nondipolar
SPM ParametersTable 3 BSPM Parameters
Baseline Peak Ajmaline
BrS
(n  40)
Controls
(n  54)
BrS
(n  40)
Controls
(n  54)
Frank leads
fQRSD (ms) 94 15 89 9 122 22 117 14
RMS40 (V) 44 23* 62 37 15 7* 21 15
LAS40 (ms) 3211* 28 9 52 17† 43 12
Left precordial leads
fQRSD (ms) 93 16 90 9 117 22 117 14
RMS40 (V) 72 50 87 67 24 20 25 24
LAS40 (ms) 31 12 28 10 44 17 41 13
Right precordial leads
fQRSD (ms) 105 18* 96 9 142 23† 125 14
RMS40 (V) 39 24† 61 37 15 9† 28 19
LAS40 (ms) 27 10† 21 10 51 18† 36 15
Nondipolar content (%) 10 5 8 4 12 8 8 4
ata are mean  SD. *p  0.05. †p  0.01 for Brugada syndrome (BrS) patients versus controls.
BSPM body surface potential map; fQRSD filtered QRS complex duration; LAS40 duration
f low amplitude signal (40 V) in the terminal part of the filtered QRS complex; RMS40  root
ean square value of voltage in the terminal 40 ms of the filtered QRS complex.
Vectorcardiogram ParametersTable 4 Vectorcardiogram Parameters
(
Duration first quarter of spatial QRS loop (ms) 3
Duration second quarter of spatial QRS loop (ms) 1
Duration third quarter of spatial QRS loop (ms) 1
Duration fourth quarter of spatial QRS loop (ms) 4
Axis fourth quarter of spatial QRS loop (degrees)‡ 7
Ventricular gradient (mV·ms)§ 3
Spatial QRS T angle (°) 6Data are mean  SD. *p  0.05. †p  0.01 for Brugada syndrome (BrS) pat
at the X axis. §Vector magnitude of the spatial QRS T integral.ontent of 19% (23) (baseline: 3 [8%] vs. 2 [4%], peak
jmaline effect: 6 [15%] vs. 4 [7%]; p  NS).
The ECG and BSPM finding that the occurrence of a
ype 1 ECG in BrS patients was not associated with local
epolarization abnormalities was supported by VCG analy-
is (Table 4). BrS patients had lower ventricular gradients
baseline: 36  14 mV·ms vs. 42  18 mV·ms, peak
jmaline effect: 33  12 mV·ms vs. 40  16 mV·ms; both
values 0.05). Furthermore, the absence of discordant
epolarization was apparent from normal spatial QRS T
ngles at baseline and peak ajmaline effect, regardless of
hether a type 1 ECG occurred (peak ajmaline effect: 92 
9° vs. 87  31°, p  NS) (Table 4).
orrelation between J amplitude and depolarization
bnormalities. As final supportive evidence of the notion
hat BrS is associated with RV conduction disorders, we
ound a positive correlation between right precordial J
mplitude and RV conduction-slowing indices. J amplitude
orrelated most closely with right-to-left difference in
QRSD (fQRSD from right precordial leads minus fQRSD
rom left precordial leads; Spearman’s rho 0.411, p  0.01)
Fig. 3C). Accordingly, BrS patients had higher J ampli-
udes and greater right-to-left fQRSD differences (352 
61 V vs. 141  86 V and 25  16 ms vs. 8  10 ms,
espectively; both p values 0.01) (Online Table S1). This
orrelation also explained the lack of differences in J ampli-
ude between BrS patients with and without SCN5a muta-
ions, although fQRSD in the right precordial leads was
reater in those with SCN5a mutations (158  23 ms vs.
35  19 ms; p  0.01) (Supplemental Table S2). Because,
n BrS patients with SCN5a mutations, the left precordial
QRSD was increased to a similar extent (132  23 ms vs.
10  17 ms; p  0.01), the net right-to-left fQRSD
ifference between BrS patients with SCN5a mutations and
hose without was similar (26  16 ms vs. 25  17 ms; p 
S); thus, J amplitudes were also similar (360 167 V vs. 351
161 V; p  NS).
econdary analyses: SCN5a, sex, and symptoms. BrS
atients with SCN5a mutations had more depolarization
isorders at baseline than those without (Supplemental
able S2). Although BrS patients with SCN5a mutations
Baseline Peak Ajmaline
1)
Controls
(n  162)
BrS
(n  91)
Controls
(n  162)
33 4 44 7* 42 5
15 3 18 5 18 4
12 3 24 11* 19 7
2† 42 8 60 11† 53 9
9 80 41 55 39† 69 25
4* 42 18 33 12* 40 16
2 61 26 92 39 87 31BrS
n  9
3 5
5 3
3 5
6 1
1 4
6 1
6 3ients versus controls. ‡Axis in transverse plane with zero degrees set
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February 23, 2010:789–97 Depolarization Changes Dominate Brugada Syndromeeceived less ajmaline, the differences with regard to con-
uction velocity at atrial, atrioventricular, and ventricular
evels remained of similar magnitude at peak ajmaline effect
P: 166 18 ms vs. 153 23 ms; PQ: 234 39 ms vs. 212
7 ms; QRS: 163  31 ms vs. 143  18 ms; duration of
ourth quarter QRS loop: 66  14 ms vs. 59  10 ms; all
values 0.05). Differences with regard to all LP param-
ters in Frank and left and right precordial leads became
ven greater at peak ajmaline effect (fQRSD: Frank, 137 
5 ms vs. 115 17 ms; left precordial, 132 23 ms vs. 110 17
s; right precordial, 158  23 ms vs. 135  19 ms; all p
alues 0.01). In contrast, repolarization parameters on
CG, VCG, and BSPM were similar.
Depolarization differences between male and female BrS
atients were somewhat smaller (Supplemental Table S3).
ale BrS patients had more atrial and ventricular conduc-
ion slowing and higher fQRSD at baseline (P: 122 15 ms
s. 115  17 ms; QRS: 115  19 ms vs. 102  15 ms;
uration of fourth quarter QRS loop: 50  13 ms vs. 43 
1 ms; fQRSD: Frank, 101  16 ms vs. 87  8 ms; left
recordial, 99 19 ms vs. 85 8 ms; right precordial, 114 20
s vs. 95  10 ms; all p values 0.05). However, these
ifferences were attenuated at peak ajmaline effect (note that
emale subjects received relatively more ajmaline). In addi-
ion, female subjects had longer QTc intervals (baseline: 406
2 ms vs. 393  26 ms, peak ajmaline effect: 472  29 ms
s. 452  24 ms; both p  0.05) and lower ventricular
radients (baseline: 32  13 mV·ms vs. 41  15 mV·ms;
eak ajmaline effect: 29  11 mV·ms vs. 37  12 mV·ms;
oth p values 0.01).
Depolarization differences between symptomatic (VT/
F, unexplained syncope) and asymptomatic BrS patients
rimarily showed a trend toward more (RV) conduction
lowing (Supplemental Table S4). Most differences, existing
t baseline (QRS duration: 117  26 ms vs. 106  16 ms;
uration of fourth quarter QRS loop: 53  18 ms vs. 45 
1 ms; right precordial fQRSD: 117  31 vs. 102  14; all
values 0.05), lost significance after addition of similar
mounts of ajmaline (duration of fourth quarter QRS loop:
6  13 ms vs. 59  11 ms, p  0.05). Nondipolar content
t peak ajmaline was even lower for symptomatic BrS
atients (8  2% vs. 13  8%, p  0.05).
iscussion
e used the synergy of simultaneously recorded ECG,
CG, and BSPM to study both global and local abnormal-
ties of depolarization and repolarization during ajmaline
rovocation testing with the aim to better understand the
athophysiologic basis of BrS. The most distinctive findings
ssociated with the development of the type 1 ECG were:
) right terminal conduction delay in combination with
) increase in LPs, which were localized, in particular, in
ight precordial leads, and 3) the absence of major global or
ocal repolarization abnormalities. dWith the ECG analyses, we confirm previous reports in
hich BrS patients showed excessive conduction slowing on
odium channel blockade at the atrial, atrioventricular, and
entricular level (8). We did not find independent repolar-
zation abnormalities: QT and QTc interval and Tpeak-Tend
nterval measures were similar between BrS patients and
ontrols. Instead, repolarization adapted to conduction
lowing with JT interval shortening.
Vectorcardiography emerged as a suitable method to
uantify the characteristic RV conduction slowing associ-
ted with the type 1 ECG (4,6,18). Moreover, VCG
llowed detailed analysis of repolarization by providing
nformation on depolarization-repolarization concordance
spatial QRS T angle) and heterogeneity of action potential
uration (ventricular gradient) (19,20). These analyses re-
ealed that, although intense depolarization abnormalities
ccurred with the type 1 ECG occurrence, repolarization
emained concordant. This suggests that the abnormal deep
egative T waves in right precordial leads, which constitute
he type 1 ECG, reflect an abnormal repolarization pattern
hat simply follows an abnormal depolarization pattern and
hat abnormal repolarization is not the inciting mechanism.
urthermore, instead of an increase in the ventricular
radient that would be associated with increased heteroge-
eity of action potential duration (20), the ventricular
radient decreased. This is consistent with the notion that
he net left ventricular contribution to the QRS T integral
s effectively cancelled by enhanced terminal RV conduction
elay, a process previously observed in patients with pulmo-
ary arterial hypertension (24).
BSPM analysis provided additional information on local
lectrophysiologic phenomena associated with the type 1
CG. In particular, LP analysis of right precordial leads
nderscored the role of RV LPs in the type 1 ECG
evelopment (25). LPs can be caused by lengthening of the
athway of excitation and/or by conduction slowing, with
tructural disruptions as possible critical determinants (22).
s impulse propagation is determined by both active and
assive membrane properties, it is likely that LPs in BrS are
ccentuated by disruptions in both properties (6). Abnormal
embrane excitability causing conduction slowing in BrS
ay follow from reduced sodium current through reduced
arcolemmal sodium channel density or changes in sodium
hannel function. The additive effect of ajmaline and
CN5a mutations on LPs supports the role of decreased
odium channel availability. In addition, increased coupling
esistance between cells (e.g., by separation of myocardial
bers by fibrosis or fat or by decreased connexin expression)
ill slow conduction, lengthen the excitation pathway, and
esult in a discontinuously traveling electrical impulse and
Ps (4,6,22). Interestingly, fibrosis and reduced connexin
xpression may also result from decreased sodium current
4). Further, in accordance with the ECG and VCG
nalyses and earlier studies (4,5,25), repolarization on
SPM (nondipolar content, a sensitive marker of local
isparity of repolarization duration [23]) did not indicate
l
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Depolarization Changes Dominate Brugada Syndrome February 23, 2010:789–97ocal repolarization abnormalities associated with the type 1
CG or BrS. This further supports the notion that repo-
arization abnormalities follow the depolarization abnormal-
ties because this results in a consistent QRS T integral over
he complete body surface.
From the BSPM analyses, we found that right-to-left
ifferences in conduction slowing are important. At the end
f the QRS complex, these differences will constitute an
lectrical gradient above the right ventricular outflow tract
n apicobasal and posteroanterior direction that may be of
ufficient magnitude to inscribe as right precordial J
levation on the ECG. Although SCN5a mutations are
ssociated with more conduction slowing, they are not
imited to the RV and, accordingly, do not result in
reater J amplitudes.
It is readily conceivable how excessive RV conduction
lowing, despite an apparent absence of distinct repolariza-
ion abnormalities as found in the present study, may induce
rrhythmias. It is well known that the spontaneous or
rug-induced appearance of the type-1 ECG in BrS is
ssociated with a higher risk for arrhythmias and/or sudden
ardiac death (1,26). Interestingly, the presence of (loss of
unction) SCN5a mutations, although associated with more
onduction delay, is not an independent risk factor (2). We
ound that RV, as opposed to left ventricular, conduction
elay is important to create the type 1 ECG. This might
ell explain why SCN5a mutations do not result in higher
rrhythmic risk. The mechanism by which local conduction
lowing results in an arrhythmic substrate probably lies in a
ombination of factors (6): local reduction of wavelength in
ombination with augmented anisotropy and discontinuous
onduction due to interstitial changes and/or electrical
ncoupling. This will promote conduction block, reentry,
nd wave break and may result in VT/VF. However, the
rognostic value of larger right-left differences in conduc-
ion slowing, measured either invasively or noninvasively,
eeds to be confirmed in large and long-term follow-up
tudies.
In summary, by simultaneously recording ECGs, VCGs,
nd BSPMs during ajmaline provocation testing, we found
hat RV conduction slowing is essential in the development
f the type 1 ECG in BrS. These findings support previous
tudies in which dominant depolarization abnormalities
nd no distinctive repolarization abnormalities were found
4–6,25). These depolarization abnormalities, rather than
bnormal repolarization, seem to be the primary pathophys-
ologic basis of the coved-type ST segment with J elevation
nd deep negative T-wave.
tudy limitations. First, although we found no evidence of
ndependent repolarization abnormalities associated with
he type 1 ECG, we cannot rule out that transmural
ispersion of action potential morphology (7) plays a role.
lthough the techniques used are considered reliable meth-
ds to study abnormal cardiac electrophysiology and suitable
o study (transmural) dispersion of action potential mor-
hology (9,16,20,23), it is possible that they cannot detectubtle disparities. Second, we used various parameters to
istinguish between global and/or local depolarization and
epolarization abnormalities associated with the type 1
CG. In view of the explorative nature of this study,
orrection for multiple testing was not performed (27). This
ould make our results more prone to type I errors. Because
any of the studied parameters exhibited considerable
verlap (as expected) and concordant presence or absence of
ignificant differences was found, we are confident that this
imitation is subsidiary. Finally, the secondary analyses into
he role of SCN5a mutations, sex, and symptoms were
ampered by smaller numbers of subjects.
onclusions
he type 1 BrS ECG is characterized predominantly by
ocalized depolarization abnormalities, notably (terminal)
onduction delay in the RV, as assessed with complemen-
ary noninvasive electrocardiographic techniques. We could
ot define a separate role for repolarization abnormalities
ut suggest that the typical signs of repolarization derange-
ents seen on the ECG are secondary to these depolariza-
ion abnormalities.
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